Публикация в канале «MarketTwits»

🇬🇧#AZN #отчетность

AstraZeneca Q3 2026 Earnings

• Core EPS: $2.79 (est $2.62)
• Revenue: $16.21B (est $15.98B)
• Core Operating Margin: 36% (est 33.6%)
• Reconfirms Revenue And Core EPS Guidance

Источник